Epstein-Barr viral load measurement as a marker of EBV-related disease

Hongxin Fan, Margaret L. Gulley

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Epstein-Barr virus (EBV) is associated with a wide variety of benign and neoplastic diseases. EBV viral load assays that may prove useful in rapid assessment of disease status are now available. The two most common approaches to viral load measurement are quantitative, competitive PCR, and real-time PCR. Laboratory studies have shown that these assays are sensitive and specific for measuring EBV DNA in blood samples. Clinical investigations suggest a role for viral load measurement in predicting and monitoring EBV-associated tumors, including nasopharyngeal carcinoma, post-transplant lymphoproliferative disorder, Hodgkin's disease, and AIDS-related lymphoma. These new laboratory tools show promise in improving clinical management of affected patients.

Original languageEnglish (US)
Pages (from-to)279-289
Number of pages11
JournalMolecular Diagnosis
Volume6
Issue number4
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Virus Diseases
Viral Load
Human Herpesvirus 4
AIDS-Related Lymphoma
Lymphoproliferative Disorders
Hodgkin Disease
Real-Time Polymerase Chain Reaction
Transplants
Polymerase Chain Reaction
DNA
Neoplasms

Keywords

  • Infectious mononucleosis
  • Nasopharyngeal carcinoma
  • Post-transplant lymphoproliferation
  • Quantitative PCR

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Epstein-Barr viral load measurement as a marker of EBV-related disease. / Fan, Hongxin; Gulley, Margaret L.

In: Molecular Diagnosis, Vol. 6, No. 4, 2001, p. 279-289.

Research output: Contribution to journalArticle

Fan, Hongxin ; Gulley, Margaret L. / Epstein-Barr viral load measurement as a marker of EBV-related disease. In: Molecular Diagnosis. 2001 ; Vol. 6, No. 4. pp. 279-289.
@article{8dc614ca28da4fcfb73fd3e5ad5eddcb,
title = "Epstein-Barr viral load measurement as a marker of EBV-related disease",
abstract = "Epstein-Barr virus (EBV) is associated with a wide variety of benign and neoplastic diseases. EBV viral load assays that may prove useful in rapid assessment of disease status are now available. The two most common approaches to viral load measurement are quantitative, competitive PCR, and real-time PCR. Laboratory studies have shown that these assays are sensitive and specific for measuring EBV DNA in blood samples. Clinical investigations suggest a role for viral load measurement in predicting and monitoring EBV-associated tumors, including nasopharyngeal carcinoma, post-transplant lymphoproliferative disorder, Hodgkin's disease, and AIDS-related lymphoma. These new laboratory tools show promise in improving clinical management of affected patients.",
keywords = "Infectious mononucleosis, Nasopharyngeal carcinoma, Post-transplant lymphoproliferation, Quantitative PCR",
author = "Hongxin Fan and Gulley, {Margaret L.}",
year = "2001",
doi = "10.1054/modi.2001.29161",
language = "English (US)",
volume = "6",
pages = "279--289",
journal = "Molecular Diagnosis and Therapy",
issn = "1177-1062",
publisher = "Adis International Ltd",
number = "4",

}

TY - JOUR

T1 - Epstein-Barr viral load measurement as a marker of EBV-related disease

AU - Fan, Hongxin

AU - Gulley, Margaret L.

PY - 2001

Y1 - 2001

N2 - Epstein-Barr virus (EBV) is associated with a wide variety of benign and neoplastic diseases. EBV viral load assays that may prove useful in rapid assessment of disease status are now available. The two most common approaches to viral load measurement are quantitative, competitive PCR, and real-time PCR. Laboratory studies have shown that these assays are sensitive and specific for measuring EBV DNA in blood samples. Clinical investigations suggest a role for viral load measurement in predicting and monitoring EBV-associated tumors, including nasopharyngeal carcinoma, post-transplant lymphoproliferative disorder, Hodgkin's disease, and AIDS-related lymphoma. These new laboratory tools show promise in improving clinical management of affected patients.

AB - Epstein-Barr virus (EBV) is associated with a wide variety of benign and neoplastic diseases. EBV viral load assays that may prove useful in rapid assessment of disease status are now available. The two most common approaches to viral load measurement are quantitative, competitive PCR, and real-time PCR. Laboratory studies have shown that these assays are sensitive and specific for measuring EBV DNA in blood samples. Clinical investigations suggest a role for viral load measurement in predicting and monitoring EBV-associated tumors, including nasopharyngeal carcinoma, post-transplant lymphoproliferative disorder, Hodgkin's disease, and AIDS-related lymphoma. These new laboratory tools show promise in improving clinical management of affected patients.

KW - Infectious mononucleosis

KW - Nasopharyngeal carcinoma

KW - Post-transplant lymphoproliferation

KW - Quantitative PCR

UR - http://www.scopus.com/inward/record.url?scp=0035671576&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035671576&partnerID=8YFLogxK

U2 - 10.1054/modi.2001.29161

DO - 10.1054/modi.2001.29161

M3 - Article

C2 - 11774193

AN - SCOPUS:0035671576

VL - 6

SP - 279

EP - 289

JO - Molecular Diagnosis and Therapy

JF - Molecular Diagnosis and Therapy

SN - 1177-1062

IS - 4

ER -